6533b7d4fe1ef96bd1262812
RESEARCH PRODUCT
Feasibility of the Allergy Questionnaire for Athletes (AQUA © ) in pediatric age
Ilaria BaiardiniMarianna BellafioreStefano Del GiaccoMatteo BoniniGiuliana FerranteStefania La GruttaSalvatore Fasolasubject
medicine.medical_specialtyAllergyCross-sectional studyself-reports.ImmunologyMEDLINEAtopy03 medical and health sciences0302 clinical medicinemedicineImmunology and Allergy030212 general & internal medicineAsthmayoung athletesSettore M-EDF/02 - Metodi E Didattiche Delle Attivita' SportivebiologyAthletesbusiness.industrySettore MED/09 - MEDICINA INTERNAAQUA© questionnaireAdolescent; Athletes; Child; Cross-Sectional Studies; Feasibility Studies; Female; Humans; Hypersensitivity; Male; Sports; Surveys and Questionnaires; Pediatrics Perinatology and Child Health; Immunology and Allergy; ImmunologyPediatric ageself-reportsmedicine.diseasebiology.organism_classification030228 respiratory systemFamily medicinePediatrics Perinatology and Child Healthallergy symptoms AQUA© questionnaire feasibility linguistic adaptation young athletes missing answers self-reports.businessSettore M-EDF/01 - Metodi E Didattiche Delle Attivita' Motorieallergy symptomsfeasibilitydescription
A burden of respiratory and allergic symptoms up to almost 60% has been observed in young and adult athletes, influencing physical performances1 . The Allergy Questionnaire for Athletes (AQUA©) is a validated screening tool for the prediction of the atopic status in adult athletes2 ; it was recently tested in Belgian young elite athletes (12-14 years old)3 , but its actual feasibility and suitability for children and adolescent was not evaluated. Indeed, there is evidence that children are prone to employ "satisficing" response strategies, answering every question positively/negatively, or simply not answering4 . Therefore, the present cross-sectional survey was carried out to assess feasibility of a linguistically simplified version of AQUA© in children and adolescents, stratifying by sport practice and focusing on the core items (12 questions, 5 to 14 and 16 to 17) related to allergy. The study was approved by the local Institutional Ethics Committee (Palermo 1, Italy, Approval Number: 07/2017), and registered on the central registration system ClinicalTrials. gov (ID: NCT03286894). This article is protected by copyright. All rights reserved.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2018-12-13 | Pediatric Allergy and Immunology |